Stock VXL VAXIL BIO LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Vaxil Bio Ltd.

Equities

VXL

CA92243L1076

Market Closed - Toronto S.E.
Other stock markets
 09:30:25 2024-04-24 am EDT 		5-day change 1st Jan Change
0.01 CAD 0.00% Intraday chart for Vaxil Bio Ltd. -33.33% -60.00%
Mar. 04 Copper Bullet Mines Inc. cancelled the acquisition of Vaxil Bio Ltd. in a reverse merger transaction. CI
Jan. 10 Vaxil Bio Entered Into Letter Of Intent With Copper Bullet Mines In Respect Of A Proposed Reverse Takeover MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Vaxil Bio Proposed Reverse Takeover with Copper Bullet Terminated and Update of Research Activities
GL
Copper Bullet Mines Inc. cancelled the acquisition of Vaxil Bio Ltd. in a reverse merger transaction.
CI
Vaxil Bio Entered Into Letter Of Intent With Copper Bullet Mines In Respect Of A Proposed Reverse Takeover
MT
Vaxil Bio Enters Into Letter of Intent With Copper Bullet Mines in Respect of a Proposed Reverse Takeover
GL
Canadian Investment Regulatory Organization Trading Halt - VXL
AQ
Copper Bullet Mines Inc. entered into a non-binding letter of intent to acquire Vaxil Bio Ltd. for CAD 15.8 million in a reverse merger transaction.
CI
Vaxil Bio Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Vaxil Bio Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Vaxil Provides Update on Research Activities and Management Changes
GL
Vaxil Bio Ltd. Announces CFO Changes
CI
Vaxil Bio Ltd. Announces CEO Changes
CI
Vaxil Bio Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Vaxil Bio Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Vaxil Bio Ltd. Auditor Raises 'Going Concern' Doubt
CI
Vaxil’s Annual and Special Shareholders Meeting
GL
Vaxil’s Annual and Special Shareholders Meeting
AQ
Vaxil Bio Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Vaxil Bio Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Vaxil Bio Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Vaxil Bio Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VXL Stock
  4. News Vaxil Bio Ltd.